SCHEMBL7202440

SCHEMBL7202440

NCCCCNCCCN(CCCNCCCCN)Cc1ccccc1

nearest known ligand 0.94

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7205397 0.95 REN (0.49) REN
SCHEMBL9182734 0.89 HDAC3 (0.50)
SCHEMBL22633373 0.89 KCNH2 (0.44)
SCHEMBL7206733 0.87 MAOA (0.53)
SCHEMBL17508108 0.86 MAOA (0.54)
SCHEMBL3666097 0.84 MAOA (0.52)
SCHEMBL17527067 0.84 MAOA (0.52)
SCHEMBL17527074 0.84 MAOA (0.52)
SCHEMBL16390835 0.84 MAOA (0.52)
SCHEMBL7202171 0.84 MAOA (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6605645-B2 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action RIKEN (JP) 2003-08-12 US disclosed
US-20020067472-A1 Linear polyamine compounds and polyamine anticancer agents IWATA MASAAKI (JP) 2002-06-06 US disclosed
US-6319956-B1 N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. RIKEN (JP) 2001-11-20 US disclosed